Healthcare -
Biotechnology - NASDAQ - US
$ 23.46
-0.509 %
$ 3.38 B
Market Cap
-8.5
P/E
DNLI - STOCK-BASED COMPENSATION
Stock-based Compensation DNLI - Denali Therapeutics Inc.
108 M
LAST VALUE
12.61%
2 YEAR CAGR
41.90%
5 YEAR CAGR
0.00%
10 YEAR CAGR